Literature DB >> 10813300

Factors of importance for work disability in women with fibromyalgia.

C Henriksson1, G Liedberg.   

Abstract

OBJECTIVE: To identify factors of importance for women with fibromyalgia (FM) to continue working despite the limitations imposed by the symptoms.
METHODS: A mail questionnaire with questions regarding social background, symptoms, sickness benefits, work situation, work conditions and adjustments, opinions regarding own work ability, and satisfaction with the situation was sent to 218 consecutive women seen at a university pain or rheumatology clinic. Answers were obtained from 176 women.
RESULTS: Pain, poor quality sleep, abnormal tiredness, muscle stiffness, and increased pain after muscle exertion were frequently reported symptoms. Fifty percent of the women were employed, 15% full-time. Twenty-three percent reported FM as the reason for not working. The work situation had been changed for 58% of the working women, and 80% counted on being able to continue working.
CONCLUSION: Work disability is a serious concern in FM, and the majority of women with FM have limitations in their ability to work. Our results indicate that individual adjustments in the work situation need to be made and that women who have found a level matching their ability may continue to work and find it satisfactory. Early intervention in the work situation is recommended.

Entities:  

Mesh:

Year:  2000        PMID: 10813300

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Factors associated with temporary work disability in patients with fibromyalgia.

Authors:  J Rivera; J Esteve-Vives; M A Vallejo; J Rejas
Journal:  Rheumatol Int       Date:  2010-05-16       Impact factor: 2.631

Review 2.  Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden.

Authors:  Tracy L Skaer
Journal:  Pharmacoeconomics       Date:  2014-05       Impact factor: 4.981

Review 3.  Societal and patient burden of fibromyalgia syndrome.

Authors:  Lieven Annemans; Katell Le Lay; Charles Taïeb
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; Don L Goldenberg; John X Pereira; Susan Abbey; Manon Choinière; Gordon Ko; Dwight E Moulin; Pantelis Panopalis; Johanne Proulx; Yoram Shir
Journal:  Pain Res Manag       Date:  2013 May-Jun       Impact factor: 3.037

5.  Which aspects of health differ between working and nonworking women with fibromyalgia? A cross-sectional study of work status and health.

Authors:  Annie Palstam; Jan L Bjersing; Kaisa Mannerkorpi
Journal:  BMC Public Health       Date:  2012-12-14       Impact factor: 3.295

Review 6.  Quality-of-life, legal-financial, and disability issues in fibromyalgia.

Authors:  D J Wallace; D S Hallegua
Journal:  Curr Pain Headache Rep       Date:  2001-08

7.  The lived experience of fibromyalgia in female patients, a phenomenological study.

Authors:  Francesca Wuytack; Peter Miller
Journal:  Chiropr Man Therap       Date:  2011-09-19

8.  Adjudication of fibromyalgia syndrome: challenges in the medicolegal arena.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; Angela Mailis; Yoram Shir
Journal:  Pain Res Manag       Date:  2014 Nov-Dec       Impact factor: 3.037

9.  General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study.

Authors:  Karin Björkegren; Mari-Ann Wallander; Saga Johansson; Kurt Svärdsudd
Journal:  BMC Public Health       Date:  2009-10-31       Impact factor: 3.295

10.  Decrease of fear avoidance beliefs following person-centered progressive resistance exercise contributes to reduced pain disability in women with fibromyalgia: secondary exploratory analyses from a randomized controlled trial.

Authors:  Annie Palstam; Anette Larsson; Monika Löfgren; Malin Ernberg; Jan Bjersing; Indre Bileviciute-Ljungar; Björn Gerdle; Eva Kosek; Kaisa Mannerkorpi
Journal:  Arthritis Res Ther       Date:  2016-05-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.